Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06329700
What this trial is testing

Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy

Who this might be right for
Colorectal Cancer Stage IV
Azienda Ospedaliero Universitaria Maggiore della Carita 74
Testing effectiveness (Phase 2)Study completedNCT02001519
What this trial is testing

Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Asan Medical Center 88
Testing effectiveness (Phase 2)UnknownNCT02027363
What this trial is testing

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients

Who this might be right for
Colorectal NeoplasmsNeoplasms Metastasis
Sun Yat-sen University 245
Not applicableWithdrawnNCT03503071
What this trial is testing

Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy

Who this might be right for
Colorectal Cancer Metastatic
Kyungpook National University Hospital
Testing effectiveness (Phase 2)Study completedNCT00429247
What this trial is testing

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients

Who this might be right for
Breast Cancer
University Hospital of Crete 75
Not applicableLooking for participantsNCT05763641
What this trial is testing

TAD After Chemotherapy in Locally Advanced Breast Cancer

Who this might be right for
Sentinel Lymph NodeBreast CancerLocally Advanced
Hospital Universitari de Bellvitge 162
Testing effectiveness (Phase 2)Looking for participantsNCT07260175
What this trial is testing

Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaIDH Mutation
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Not applicableStudy completedNCT01457287
What this trial is testing

A Longitudinal Investigation of Cognitive Function in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
University Health Network, Toronto 300
Large-scale testing (Phase 3)Looking for participantsNCT07566052
What this trial is testing

Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Astellas Pharma Global Development, Inc. 356
Testing effectiveness (Phase 2)Study completedNCT01035463
What this trial is testing

Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeRecurrent Anaplastic Large Cell LymphomaRecurrent Mantle Cell Lymphoma+3 more
University of Nebraska 74
Testing effectiveness (Phase 2)UnknownNCT00980304
What this trial is testing

R Retreatment in 1st Relapsed DLBCL

Who this might be right for
Lymphomas
Shanghai Jiao Tong University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT00100932
What this trial is testing

Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eisai Inc. 106
Not applicableUnknownNCT04917263
What this trial is testing

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.

Who this might be right for
Rectal Cancer
University of Padova 544
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Not applicableUnknownNCT05634694
What this trial is testing

Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients

Who this might be right for
Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Testing effectiveness (Phase 2)UnknownNCT05990231
What this trial is testing

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Testing effectiveness (Phase 2)Study completedNCT01465802
What this trial is testing

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Pfizer 236
Testing effectiveness (Phase 2)UnknownNCT02404753
What this trial is testing

A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Gastric Cancer
Peking University 102
Testing effectiveness (Phase 2)UnknownNCT04150575
What this trial is testing

A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy

Who this might be right for
Cervical Cancer
Shanghai Henlius Biotech 21
Next Page